Home >> Vascular Disease Prevention, Volume 1, Number 3

Medical Treatment of Peripheral Arterial Disease: Current Concepts and Future Options

Authors: Frank Schroder; Thomas Weiss

Source: Vascular Disease Prevention, Volume 1, Number 3, November 2004 , pp. 211-218(8)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

OR

Price: $63.10 plus tax (Refund Policy)

Abstract:

Peripheral arterial disease (PAD) has an increasing prevalence and incidence; 30% of the patients with intermittent claudication die within 5 years. Therapeutic goals are therefore a reduction of the high cardiovascular mortality and improvement of the ischaemic symptoms. The review describes the medical treatment options for the different stages of PAD and focuses on new treatment strategies, like the local application of growth factors or autologous stem cells.

Keywords: peripheral arterial disease; medical treatment; vasoactive drugs; new treatment strategies

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1567270043405006

Affiliations: 1: Department of Cardiology and Angiology, Medical School of Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Publication date: 2004-11-01

More about this publication?
  • Vascular Disease Prevention publishes reviews as well as original papers to update all those concerned with this topic at the clinical or scientific level. In addition to clinically relevant topics, we consider reviews and original papers dealing with the more scientific aspects of vascular disease prevention. This includes the evaluation of emerging vascular risk factors, research dealing with the pathogenesis of atherosclerosis and the investigation of new treatment options both at the clinical and scientific level (e.g. epidemiology, patient-based studies, experimental models, in vitro experiments or molecular research). Therefore, another function of Vascular Disease Prevention is to bridge the gap between clinical practice and ongoing laboratory-based research.

    In particular, we welcome critical reviews and comments on recent trials. This is a topic that requires regular updates because of the large number of trials published every year.

    Debates are encouraged in the correspondence section of this journal.
    The editorial structure of Vascular Disease Prevention is set up with the aim of dealing with the submitted material as rapidly as possible. Specialist editors will provide a more expert and rapid assessment unlike a more centralized editorial structure.
Related content
Marked list

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page